Germany jurisdiction report: First compulsory licence for a pharma product

20-10-2017

Jochen Bühling

Germany jurisdiction report: First compulsory licence for a pharma product

In a landmark decision on July 11, 2017, the German Federal Court of Justice (Bundesgerichtshof) for the first time confirmed the grant of a compulsory licence under the German Patent Act (docket no. X ZB 2/17).


German Federal Court of Justice, Jochen Bühling, Krieger Mes & Graf v. der Groeben, , Merck, pharma, patent, compulsory licence, , landmark, petitioners

WIPR